Scott Koenig
2021
In 2021, Scott Koenig earned a total compensation of $4.9M as President, Chief Executive Officer and Director at MacroGenics, a 56% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $294,323 |
---|---|
Option Awards | $3,914,372 |
Salary | $651,119 |
Other | $8,700 |
Total | $4,868,514 |
Koenig received $3.9M in option awards, accounting for 80% of the total pay in 2021.
Koenig also received $294.3K in non-equity incentive plan, $651.1K in salary and $8.7K in other compensation.
Rankings
In 2021, Scott Koenig's compensation ranked 2,707th out of 12,415 executives tracked by ExecPay. In other words, Koenig earned more than 78.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,707 out of 12,415 | 78th |
Division Manufacturing | 1,069 out of 5,508 | 81st |
Major group Chemicals And Allied Products | 420 out of 2,378 | 82nd |
Industry group Drugs | 366 out of 2,099 | 83rd |
Industry Pharmaceutical Preparations | 242 out of 1,549 | 84th |
Source: SEC filing on April 8, 2022.
Koenig's colleagues
We found four more compensation records of executives who worked with Scott Koenig at MacroGenics in 2021.
News
MacroGenics CEO Scott Koenig's 2023 pay slips 20% to $3.7M
April 8, 2024
MacroGenics CEO Scott Koenig's 2022 pay slips 5% to $4.6M
April 17, 2023
MacroGenics CEO Scott Koenig's 2021 pay jumps 56% to $4.9M
April 8, 2022
MacroGenics Chief Medical Officer Stephen Eck receives $5.1M in 2020
April 1, 2021
MacroGenics CEO Scott Koenig's 2019 pay slips 9% to $4.7M
April 2, 2020